Quest Diagnostics Stock-Based Compensation — Historical Data
Quest Diagnostics (DGX) stock-based compensation was $88M in FY2025 (+0% YoY). The tables below show the complete quarterly and annual stock-based compensation history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Stock-Based Compensation
Fiscal Year
Stock-Based Compensation
YoY
2025
$88M
+0%
2024
$88M
+14%
2023
$77M
+0%
2022
$77M
-3%
2021
$79M
-19%
2020
$97M
+73%
2019
$56M
-8%
2018
$61M
-23%
2017
$79M
+14%
2016
$69M
+33%
2015
$52M
+2%
2014
$51M
+82%
2013
$28M
-44%
2012
$50M
-31%
2011
$72M
+34%
2010
$54M
-28%
2009
$75M
+6%
2008
$71M
+24%
2007
$57M
Recent Quarterly Stock-Based Compensation
Quarter
Stock-Based Compensation
Q2 2026
$23M
Q1 2026
$20M
Q4 2025
$25M
Q3 2025
$20M
Q2 2025
$21M
Q1 2025
$22M
Q4 2024
$27M
Q3 2024
$19M
Q2 2024
$20M
Q1 2024
$22M
Q4 2023
$19M
Q3 2023
$18M
Source: DGX on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.